Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Imaging|August 2, 2012
PET Imaging in Recurrent Medullary Thyroid CarcinomaGiorgio Treglia, Vittoria Rufini, Massimo Salvatori, et al.
Clinical Nuclear Medicine|June 24, 2024
Atypical Presentation of Splenic Tissue Mimicking Neuroendocrine Tumor RelapseAndrea Guarneri, Vittoria Rufini, Giovanni Schinzari, et al.
Pediatric Blood & Cancer|February 24, 2011
Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimenStefano Mastrangelo, Vittoria Rufini, Antonio Ruggiero, et al.
Clinical Nuclear Medicine|December 6, 2018
Richter Syndrome Presenting With Colon LocalizationMariadea Lavalle, Laura Maria Minordi, Stefan Hohaus, et al.
Clinical Nuclear Medicine|October 26, 2018
68Ga-DOTATOC PET/CT in Thyroid Metastases of Lung CarcinoidLucia Leccisotti, Margherita Lorusso, Elisa Giannetta, et al.
Annals of Nuclear Medicine|February 22, 2018
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET)Salvatore Annunziata, Annarosa Cuccaro, Maria Chiara Tisi, et al.
Clinical Nuclear Medicine|December 7, 2016
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple MyelomaCarmelo Caldarella, Salvatore Annunziata, Livio Pagano, et al.
Clinical Endocrinology|December 8, 2004
Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?Massimo Salvatori, Germano Perotti, Vittoria Rufini, et al.
Clinical Imaging|May 1, 2012
18F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic reviewGiorgio Treglia, Paoletta Mirk, Antonella Stefanelli, et al.
Clinical Nuclear Medicine|January 25, 2020
Which Is the Optimal Scan Time of 18F-DOPA PET/CT in Patients With Recurrent Medullary Thyroid Carcinoma?: Results From a Dynamic Acquisition StudySilvia Taralli, Margherita Lorusso, Amedeo Capotosti, et al.
Pageof 11